Abbott Laboratories plans to spin off nutrition business, following years of tumult over infant formulas
Abbott Laboratories plans to spin off its nutrition business into a separate company – a move that follows years of tumult over its infant formulas. The new business will sell Abbott products including Similac, PediaSure, Pedialyte, Glucerna and Ensure. The company also makes medical tests, medical devices and generic pharmaceuticals. The new company is expected to have $8.5 billion in annual ...